Edwards Lifesciences (EW) Cash from Investing Activities Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.30% |
| Dec 31, 2025 | 5.27% |
| Sep 30, 2025 | -27.63% |
| Jun 30, 2025 | -75.97% |
| Mar 31, 2025 | 21.37% |
| Dec 31, 2024 | -5.31% |
| Sep 30, 2024 | 192.67% |
| Jun 30, 2024 | 27.83% |
| Mar 31, 2024 | 26.78% |
| Dec 31, 2023 | 19.86% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | -7.72% |
| Mar 31, 2023 | -70.41% |
| Dec 31, 2022 | 13.95% |
| Sep 30, 2022 | 0.78% |
| Jun 30, 2022 | 17.11% |
| Mar 31, 2022 | 8.70% |
| Dec 31, 2021 | -69.63% |
| Sep 30, 2021 | -150.57% |
| Jun 30, 2021 | 0.81% |
| Mar 31, 2021 | -24.99% |
| Dec 31, 2020 | -63.04% |
| Sep 30, 2020 | 6.38% |
| Jun 30, 2020 | -23.01% |
| Mar 31, 2020 | 5.66% |
| Dec 31, 2019 | -42.98% |
| Sep 30, 2019 | 39.35% |
| Jun 30, 2019 | 28.44% |
| Mar 31, 2019 | 16.20% |
| Dec 31, 2018 | 15.13% |
| Sep 30, 2018 | -19.00% |
| Jun 30, 2018 | 28.01% |
| Mar 31, 2018 | 74.28% |
| Dec 31, 2017 | 12.47% |
| Sep 30, 2017 | -9.70% |
| Jun 30, 2017 | -71.75% |
| Mar 31, 2017 | 17.19% |
| Dec 31, 2016 | 22.34% |
| Sep 30, 2016 | -41.16% |
| Jun 30, 2016 | -11.92% |
| Mar 31, 2016 | 18.12% |
| Dec 31, 2015 | 26.05% |
| Sep 30, 2015 | -63.13% |
| Jun 30, 2015 | 22.41% |
| Mar 31, 2015 | -94.36% |
| Dec 31, 2014 | 55.34% |
| Sep 30, 2014 | -37.44% |